8.47

2.49% 0.20

CorMedix Inc (CRMD)

Panoramica Notizia Cronologia dei prezzi Catena di opzioni Forum Previsione Frazionamento azionario

Precedente Chiudi:

$8.27

Aprire:

$8.29

Volume 24 ore:

441.89K

Relative Volume:

0.33

Capitalizzazione di mercato:

$664.10M

Reddito:

$311.71M

Utile/perdita netta:

$163.05M

Rapporto P/E:

4.2702

EPS:

1.9835

Flusso di cassa netto:

$172.79M

1 W Prestazione:

+6.88%

1M Prestazione:

+8.38%

6M Prestazione:

-12.17%

1 anno Prestazione:

-32.36%

Intervallo 1D:

$8.25

$8.535

Intervallo di 1 settimana:

$7.77

$8.535

Portata 52W:

$6.125

$17.43

CorMedix Inc Stock (CRMD) Company Profile

Nome

CorMedix Inc

Settore

Healthcare (1111)

Industria

Biotechnology (621)

Telefono

908-517-9500

Indirizzo

400 Connell Drive, 5th Floor, Suite 5000, Berkeley Heights, NJ

Dipendente

Cinguettio

Prossima data di guadagno

2026-05-14

Ultimi documenti SEC

CRMD's Discussions on Twitter

Compare CRMD vs VRTX, REGN, ARGX, ALNY, RVMD

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
CRMD CorMedix Inc	8.465	648.80M	311.71M	163.05M	172.79M	1.9835
VRTX Vertex Pharmaceuticals Inc	441.89	110.64B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	630.40	66.53B	14.92B	4.42B	3.79B	41.04
ARGX Argen X Se Adr	821.93	50.27B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	294.65	39.45B	4.29B	577.22M	641.34M	4.2086
RVMD Revolution Medicines Inc	152.59	32.93B	742.00K	-1.37B	-1.07B	-7.0731

CorMedix Inc Stock (CRMD) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-10-20	Aggiornamento	D. Boral Capital	Hold → Buy
2025-06-30	Downgrade	D. Boral Capital	Buy → Hold
2025-06-30	Iniziato	H.C. Wainwright	Buy
2025-03-07	Iniziato	Leerink Partners	Outperform
2025-01-13	Iniziato	D. Boral Capital	Buy
2024-08-26	Iniziato	Rodman & Renshaw	Buy
2023-08-10	Iniziato	RBC Capital Mkts	Outperform
2021-02-17	Iniziato	Needham	Buy
2020-09-29	Iniziato	JMP Securities	Mkt Outperform
2020-09-21	Iniziato	Truist	Buy
2019-12-18	Iniziato	B. Riley FBR	Buy
2019-03-26	Reiterato	H.C. Wainwright	Buy
2018-12-06	Iniziato	ROTH Capital	Buy
2017-09-25	Reiterato	H.C. Wainwright	Buy
2017-08-10	Reiterato	Rodman & Renshaw	Buy
2017-05-05	Reiterato	Rodman & Renshaw	Buy
2016-11-11	Reiterato	FBR & Co.	Outperform
2016-03-17	Reiterato	FBR Capital	Outperform
2016-03-03	Iniziato	FBR Capital	Outperform
2015-11-16	Reiterato	ROTH Capital	Neutral
2015-10-29	Reiterato	ROTH Capital	Neutral
2015-05-06	Downgrade	ROTH Capital	Buy → Neutral
2014-12-08	Reiterato	ROTH Capital	Buy
2011-10-03	Downgrade	Maxim Group	Buy → Hold

Mostra tutto

CorMedix Inc Borsa (CRMD) Ultime notizie

May 25, 2026

CorMedix eyes REZZAYO expansion as DefenCath reimbursement shift looms - MSN

May 25, 2026

May 24, 2026

Cormedix outlines $325M-$345M 2026 net revenue outlook amid TDAPA transition - MSN

May 24, 2026

CorMedix Q1 earnings call highlights - MSN

May 24, 2026

May 22, 2026

CRMD: Strong growth driven by DefenCath, REZZAYO, and pipeline expansion in institutional markets - TradingView

May 22, 2026

CRMD Q1 earnings beat on DefenCath momentum, guidance raised - MSN

May 22, 2026

CorMedix Eyes REZZAYO Expansion as DefenCath Reimbursement Shift Looms - MarketBeat

May 22, 2026

CorMedix: Long-Term Prospects Remain Poor Despite Q1 Beat (NASDAQ:CRMD) - Seeking Alpha

May 18, 2026

HC Wainwright Forecasts CorMedix's Q2 Earnings (NASDAQ:CRMD) - MarketBeat

May 18, 2026

May 17, 2026

Does Strong Q1 Beat And Raised Outlook Transform The Bull Case For CorMedix (CRMD)? - Yahoo Finance

May 17, 2026

May 16, 2026

The Bull Case For CorMedix (CRMD) Could Change Following Raised 2026 Guidance And Phase III Results - simplywall.st

May 16, 2026

A Look At CorMedix (CRMD) Valuation After Strong Q1 2026 Results And Raised Full Year Guidance - Yahoo Finance

May 16, 2026